Literature DB >> 33001374

Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

P Prieto-Oliveira1.   

Abstract

Telomeres are protective structures that are shortened during the lifetime, resulting in aging and degenerative diseases. Subjects experiencing aging and degenerative disorders present smaller telomeres than young and healthy ones. The size of these structures can be stabilized by telomerase, an enzyme which is inactive in adult tissues but functional in fetal and newborn tissues and adult testes and ovaries. The aim of this study was to perform a systematic review to evaluate the effect of telomerase activation in the treatment of degenerative and aging disorders. We accomplished the search using the Pubmed interface for papers published from September 1985 to April 16th, 2020. We found twenty one studies that matched our eligibility criteria. I concluded that telomerase is probably a potential and safe treatment for aging and degenerative diseases, demonstrating neither side effects nor risk of cancer in the selected studies. Further studies in humans are needed to confirm safety and efficiency of this treatment.

Entities:  

Keywords:  Aging; Biological therapy; Enzyme activation; Systematic review; Telomerase; Telomere

Mesh:

Substances:

Year:  2020        PMID: 33001374     DOI: 10.1007/s11010-020-03929-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  96 in total

1.  Telomere length, ZNF208 genetic variants and risk of chronic obstructive pulmonary disease in the Hainan Li population.

Authors:  Yipeng Ding; Xiaoman Zhou; Cibing Wu; Quanni Li; Juan Sun; Huan Niu; Daobo Lin; Dingwei Sun; Pingdong Xie; Duoyi Wu; Jie Zhao; Ping He
Journal:  J Gene Med       Date:  2018-11-28       Impact factor: 4.565

Review 2.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

3.  Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.

Authors:  Alberto Diaz de Leon; Jennifer T Cronkhite; Cuneyt Yilmaz; Cecelia Brewington; Richard Wang; Chao Xing; Connie C W Hsia; Christine Kim Garcia
Journal:  Chest       Date:  2011-02-24       Impact factor: 9.410

4.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

Authors:  R K Moyzis; J M Buckingham; L S Cram; M Dani; L L Deaven; M D Jones; J Meyne; R L Ratliff; J R Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Angiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertension.

Authors:  Wael Farrag; Manal Eid; Sherien El-Shazly; Manal Abdallah
Journal:  Mol Cell Biochem       Date:  2011-01-14       Impact factor: 3.396

6.  Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.

Authors:  Alberto Diaz de Leon; Jennifer T Cronkhite; Anna-Luise A Katzenstein; J David Godwin; Ganesh Raghu; Craig S Glazer; Randall L Rosenblatt; Carlos E Girod; Edward R Garrity; Chao Xing; Christine Kim Garcia
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

7.  Relative Telomere Length and Stroke Risk in a Chinese Han Population.

Authors:  Dan Gao; Rui Zhang; Guofa Ji; Chunqi Li; Dangshe Guo; Tianbo Jin; Mingwei Chen
Journal:  J Mol Neurosci       Date:  2018-10-22       Impact factor: 3.444

8.  DNA methylation of human telomerase reverse transcriptase associated with leukocyte telomere length shortening in hyperhomocysteinemia-type hypertension in humans and in a rat model.

Authors:  Dong-hong Zhang; Xue-mei Wen; Lin Zhang; Wei Cui
Journal:  Circ J       Date:  2014-05-30       Impact factor: 2.993

9.  Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.

Authors:  Elena G Arias-Salgado; Eva Galvez; Lurdes Planas-Cerezales; Laura Pintado-Berninches; Elena Vallespin; Pilar Martinez; Jaime Carrillo; Laura Iarriccio; Anna Ruiz-Llobet; Albert Catalá; Isabel Badell-Serra; Luis I Gonzalez-Granado; Andrea Martín-Nalda; Mónica Martínez-Gallo; Ana Galera-Miñarro; Carmen Rodríguez-Vigil; Mariana Bastos-Oreiro; Guiomar Perez de Nanclares; Virginia Leiro-Fernández; Maria-Luz Uria; Cristina Diaz-Heredia; Claudia Valenzuela; Sara Martín; Belén López-Muñiz; Pablo Lapunzina; Julian Sevilla; María Molina-Molina; Rosario Perona; Leandro Sastre
Journal:  Orphanet J Rare Dis       Date:  2019-04-17       Impact factor: 4.123

10.  Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis: The Blood-and-Muscle Model.

Authors:  Athanase Benetos; Simon Toupance; Sylvie Gautier; Carlos Labat; Masayuki Kimura; Pascal M Rossi; Nicla Settembre; Jacques Hubert; Luc Frimat; Baptiste Bertrand; Mourad Boufi; Xavier Flecher; Nicolas Sadoul; Pascal Eschwege; Michèle Kessler; Irene P Tzanetakou; Ilias P Doulamis; Panagiotis Konstantopoulos; Aspasia Tzani; Marilina Korou; Anastasios Gkogkos; Konstantinos Perreas; Evangelos Menenakos; Georgios Samanidis; Michail Vasiloglou-Gkanis; Jeremy D Kark; Serguei Malikov; Simon Verhulst; Abraham Aviv
Journal:  Circ Res       Date:  2017-12-14       Impact factor: 17.367

View more
  1 in total

Review 1.  Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives.

Authors:  Alexander Vaiserman; Dmytro Krasnienkov
Journal:  Front Genet       Date:  2021-01-21       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.